Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-01-28

New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma

View source ↗

Summary

The EMA announces a new gene therapy for patients with relapsed or refractory large B-cell lymphoma, representing a pivotal development in treatment options for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications